Related items
Showing items related by title, author, creator and subject.
-
Comparison of new-generation drug-eluting stents versus drug-coated balloon for in-stent restenosis: a meta-analysis of randomised controlled trials.
Cai, J-Z; Zhu, Y-X; Wang, X-Y; Bourantas, CV; Iqbal, J; Zhu, H; Cummins, P; Dong, S-J; Mathur, A; Zhang, Y-J (2018-02-22)OBJECTIVE: The study sought to compare angiographic and clinical outcomes of new-generation drug-eluting stents (DES) versus drug-coated balloon (DCB) in patients with coronary in-stent restenosis (ISR). DESIGN: Meta-analysis ... -
Five-year clinical outcomes and intracoronary imaging findings of the COMFORTABLE AMI trial: randomized comparison of biodegradable polymer-based biolimus-eluting stents with bare-metal stents in patients with acute ST-segment elevation myocardial infarction
Raber, L; Yamaji, K; Kelbaek, H; Engstrom, T; Baumbach, A; Roffi, M; von Birgelen, C; Taniwaki, M; Moschovitis, A; Zaugg, S (2019-06-21) -
Targeted therapy with a localised abluminal groove, low-dose sirolimus-eluting, biodegradable polymer coronary stent (TARGET All Comers): a multicentre, open-label, randomised non-inferiority trial.
Lansky, A; Wijns, W; Xu, B; Kelbæk, H; van Royen, N; Zheng, M; Morel, M-A; Knaapen, P; Slagboom, T; Johnson, TW (Elsevier, 2018-09-29)Summary Background The FIREHAWK is a drug-eluting stent with a fully biodegradable sirolimus-containing polymer coating localised to recessed abluminal grooves on the stent surface. We investigated clinical outcomes with ...